An announcement from Pro Medicus Limited ( ($AU:PME) ) is now available. Pro Medicus Limited has cancelled 40,876 ordinary fully paid shares ...

Key Insights Pro Medicus' significant insider ownership suggests inherent interests in company's expansion 52% of ...

The latest update is out from Pro Medicus Limited ( (AU:PME)). Pro Medicus Limited has disclosed a minor change in the shareholding of Director Sam Aaron Hupert, who has increased his direct interest ...

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

The latest announcement is out from Pro Medicus Limited ( (AU:PME)). Pro Medicus Limited has announced an update regarding its ongoing on-market buy-back program, which involves the repurchase of its ...

Both Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) and Pro Medicus Ltd (ASX: PME) are viewed as compelling investments due to their strong business models. Washington H. Soul Pattinson has a ...

Morgans has issued updated ratings for several ASX 200 large-cap shares, recommending a sell for Commonwealth Bank of Australia due to overvaluation concerns and a lack of expected earnings growth, ...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Sometimes these stories can cloud the minds ...

Aussie investors are blessed with a wealth of high quality stocks operating in a variety of healthcare sectors. Healthcare globally has significant tailwinds impacting share prices. First and foremost ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

PME focuses on advanced radiology solutions. JHX leads in fibre cement building materials. ASX stock market offers diverse investment avenues. Comprehensive analysis of Pro Medicus (ASX:PME) and James ...

With its stock down 5.2% over the past three months, it is easy to disregard Pro Medicus (ASX:PME). But if you pay close attention, you might gather that its strong financials could mean that the ...